Lymphocyte activation in cutaneous drug reactions

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Drug hypersensitivity reactions are common adverse drug events.
• Understanding the specific immune cells involved is crucial for diagnosis and treatment.
• Previous studies suggested T cells play a role, but the specific subsets and their functions were unclear.

Purpose of the Study:

• To identify the T-cell subsets involved in different types of drug-induced cutaneous hypersensitivity reactions.
• To characterize the cytokine profiles and cytotoxic functions of these T cells.
• To investigate the role of drug metabolism in T-cell activation.

Main Methods:

• In vitro drug stimulation of peripheral blood lymphocytes.
• Immunohistochemical analysis of skin biopsies.
• T-cell clone generation and characterization (cytokine production, cytotoxicity assays).
• Assessment of T-cell proliferation in the presence of microsomes.

Main Results:

• CD8+ T cells were predominant in delayed reactions (maculopapular, bullous eruptions) and patch tests.
• CD8+ T cells from bullous exanthems showed a TH1-like cytokine pattern and cytotoxic activity.
• CD4+ T cells were predominant in immediate urticarial reactions, displaying a TH2-like cytokine pattern.
• Drug metabolites, potentially generated by cytochrome P450 enzymes, may be key antigens in some reactions.

Conclusions:

• Drug-induced hypersensitivity reactions involve distinct T-cell subsets and cytokine profiles.
• Delayed reactions are associated with TH1-like CD8+ T cells, while immediate reactions involve TH2-like CD4+ T cells.
• Drug metabolism likely contributes to T-cell activation in certain drug hypersensitivity reactions.